NovaBridge Biosciences (ADR) (NBP)
Develops asset-focused oncology and retinal-disease programs through dedicated therapeutic subsidiaries.
$1.79
Pre-market+0.01 (+0.56%)
At close$1.78(+2.89%)
Something off on this page? Send us feedback.
Next report
Nov 12, 2026
in 70 days
EPS estimate
−$0.08
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Apr '25May '25Nov '25Dec '25Apr '26Jun '26Jul '26Nov '26
Reported−$0.11−$0.04−$0.01−$0.25−$0.03−$0.11−$0.22Pending
Estimate−$0.06−$0.06−$0.04−$0.01−$0.01−$0.01−$0.01−$0.08
Surprise−83.3%+33.3%+76.5%−1,801.1%−528.1%−1,280.2%−2,660.4%—
RevenueReportedEstimate
Apr '25May '25Nov '25Dec '25Apr '26Jun '26Jul '26Nov '26
Reported———————Pending
Estimate$206.0K———————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.08 | — | — |
| Jul 2026 | −$0.01 | −$0.22 | −2,660.4% |
| Jun 2026 | −$0.01 | — | — |
| Jun 2026 | −$0.01 | −$0.11 | −1,280.2% |
| Apr 2026 | −$0.01 | −$0.03 | −528.1% |
| Dec 2025 | −$0.01 | −$0.25 | −1,801.1% |
The latest year is open to everyone — the 30 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| May 2025 | |||
| Apr 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Jun 2024 | |||
| Mar 2024 | |||
| Sep 2023 | |||
| Aug 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Sep 2022 | |||
| Aug 2022 | |||
| Mar 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Mar 2021 | |||
| Mar 2021 | |||
| Sep 2020 | |||
| Aug 2020 | |||
| Mar 2020 | |||
| Jan 2020 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.08 | — | — | — | — | — | — |
| Jul 29, 2026 | −$0.01 | −$0.22 | −2,660.4% | — | — | — | +1.9% |
| Jun 30, 2026 | −$0.01 | — | — | — | — | — | — |
| Jun 29, 2026 | −$0.01 | −$0.11 | −1,280.2% | — | — | — | −1.5% |
| Apr 7, 2026 | −$0.01 | −$0.03 | −528.1% | — | — | — | −1.2% |
| Dec 18, 2025 | −$0.01 | −$0.25 | −1,801.1% | — | — | — | +5.8% |
The latest year is open to everyone — the 30 quarters behind it read with an account. Sign in | |||||||
| Nov 12, 2025 | |||||||
| May 15, 2025 | |||||||
| Apr 4, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 28, 2024 | |||||||
| Jun 5, 2024 | |||||||
| Mar 29, 2024 | |||||||
| Sep 30, 2023 | |||||||
| Aug 17, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Dec 31, 2022 | |||||||
| Sep 30, 2022 | |||||||
| Aug 30, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Mar 29, 2022 | |||||||
| Nov 12, 2021 | |||||||
| Aug 31, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Mar 29, 2021 | |||||||
| Sep 30, 2020 | |||||||
| Aug 31, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Jan 17, 2020 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||